Submicroscopic chromosomal anomalies play an important role in the etiology of craniofacial malformations, including midline facial defects with hypertelorism (MFDH). MFDH is a common feature combination in several conditions, of which Frontonasal Dysplasia is the most frequently encountered manifestation; in most cases the etiology remains unknown. We identified a parent to child transmission of a 6.2 Mb interstitial deletion of chromosome region 2q36.1q36.3 by array-CGH and confirmed by FISH and microsatellite analysis. The patient and her mother both presented an MFDH phenotype although the phenotype in the mother was much milder than her daughter. Inspection of haplotype segregation within the family of 2q36.1 region suggests that the deletion arose on a chromosome derived from the maternal grandfather. Evidences based on FISH, microsatellite and array-CGH analysis point to a high frequency mosaicism for presence of a deleted region 2q36 occurring in blood of the mother. The frequency of mosaicism in other tissues could not be determined. We here suggest that the milder phenotype observed in the proband's mother can be explained by the mosaic state of the deletion. This most likely arose by an early embryonic deletion in the maternal embryo resulting in both gonadal and somatic mosaicism of two cell lines, with and without the deleted chromosome. The occurrence of gonadal mosaicism increases the recurrence risk significantly and is often either underestimated or not even taken into account in genetic counseling where new mutation is suspected.
a b s t r a c t
Submicroscopic chromosomal anomalies play an important role in the etiology of craniofacial malformations, including midline facial defects with hypertelorism (MFDH). MFDH is a common feature combination in several conditions, of which Frontonasal Dysplasia is the most frequently encountered manifestation; in most cases the etiology remains unknown. We identified a parent to child transmission of a 6.2 Mb interstitial deletion of chromosome region 2q36.1q36.3 by array-CGH and confirmed by FISH and microsatellite analysis. The patient and her mother both presented an MFDH phenotype although the phenotype in the mother was much milder than her daughter. Inspection of haplotype segregation within the family of 2q36.1 region suggests that the deletion arose on a chromosome derived from the maternal grandfather. Evidences based on FISH, microsatellite and array-CGH analysis point to a high frequency mosaicism for presence of a deleted region 2q36 occurring in blood of the mother. The frequency of mosaicism in other tissues could not be determined. We here suggest that the milder phenotype observed in the proband's mother can be explained by the mosaic state of the deletion. This most likely arose by an early embryonic deletion in the maternal embryo resulting in both gonadal and somatic mosaicism of two cell lines, with and without the deleted chromosome. The occurrence of gonadal mosaicism increases the recurrence risk significantly and is often either underestimated or not even taken into account in genetic counseling where new mutation is suspected.
Ó 2012 Elsevier Masson SAS.
Methods of detection

Cytogenetics
Conventional cytogenetic analysis of GTG-banded chromosomes from cultured lymphocytes of the proband and her mother performed at a resolution of 300e400 bands (low resolution) showed an apparently normal (46,XX) karyotype in both mother and daughter.
Array-CGH
Genomic DNA was extracted from the peripheral blood of both family members according to standard protocols. Array-CGH investigation of the proband was carried out using the 30K Whole Genome Tile Path (WGTP) BAC array from the Sanger Center (Wellcome Trust, UK) as described by Fiegler et al. [1] . All copynumber changes observed were compared to copy-number variants (CNVs) reported in previous studies at normal populations as documented in the Database of Genomic Variants (DGV; http:// projects.tcag.ca/variation/). Chromosome regions not previously reported as CNVs and comprising at least two consecutive clones were singled out for further investigate by confirmatory studies, FISH analysis and microsatellite markers. Subsequently, further high resolution CGH using a 180K Agilent platform was performed in Sao Paulo on both family members.
Chromosomal anomaly
Array-CGH analysis of the proband showed an interstitial deletion of 6. Further confirmation for the presence of mosaicism was derived from microsatellite haplotype analysis: an apparently very sensitive microsatellite allele for a locus in the center of the deletion gave a heterozygote signal in the mother when it should have been a single allele if the deletion was non-mosaic; construction of the haplotypes of the region in the entire pedigree using 5 microsatellite loci demonstrated that the deletion must have arisen on the 2q36 region derived from the maternal grandfather and that this particular allele could only have come from him ( Fig. 1) . Lastly, recently performed high resolution CGH using a 180K Agilent platform demonstrated a small yet detectable difference in the Fig. 1 . Pedigree of the family and haplotype analysis performed in family members using the microsatellite markers D2S126, D2S2197, D2S2354, D2S2308 and D2S396 at 2q36. Note an apparently very sensitive microsatellite allele for a locus located in the center of the deletion (D2S2354) gave a heterozygote signal in the mother when it should have been a single allele if the deletion was non-mosaic.
log2-ratio of probes within the deletion when DNA of the mother was hybridized against that of the daughter, suggesting an approximately 15% mosaicism in blood of the mother (Fig. 2 ).
Cause of the abnormal phenotype?
The deletion was considered as the cause of the phenotype since it is larger than 6 Mb, deleted site/region harbors more than 20 genes although EPHA4, COL4A3, COL4A4 and PAX3 of them can be considered responsible from the phenotype due to their effect at heterozygote state, by haploinsufficiency.
Clinical description
The proband was born from an AfricaneBrazilian father of 27 years and LatinoeBrazilian mother aged 23, and had two healthy sisters. The newborn had a weight of 1840 g (<3rd centile) and length of 45 cm (<3rd centile) at 38 gestational weeks. Hypotonia was the only major health concern at birth. She exhibited delayed developmental milestones, by walking at only at 2.5 years and speaking just two word sentences at 3 years. Physical examination at 11 years and 9 months (Fig. 3 ) revealed a height of 152 cm (50e75th centile), a weight of 37.4 kg (25e50th centile) and head circumference of 51.5 cm (50e10th centile). She had dolichocephaly, a broad forehead with bitemporal narrowing, low posterior hairline, hypertelorism and telecanthus (outer canthal distance 10.7 cm, >97th centile and inner canthal distance 5.2 cm, >97th centile), mild synophrys, nose with a wide and bifid base, malar flattening, overcrowded teeth within an alveolar ridge and high narrow palate, hypertrichosis and skeletal findings consisting of pectus excavatum, severe thoracolumbar scoliosis, tapering fingers and bilateral 5th finger clinodactyly. She had normal pubertal development B2P3, with normal development of axillary hair, but with hypoplasic outer vaginal lips. Ophthalmological examination and abdominal ultrasound results were normal. Neurological examination revealed mild intellectual disability, poor motor coordination and hypotonia. MRI findings showed frontal lobe anteriorization and enlarged talamic commissure.
The mother (Fig. 4) , was mentally normal, had mild hypertelorism with outer canthal distance 11.3 cm (>97th centile) and inner canthal distance 4.2 cm (>97th centile), short stature (height 146 cm, <3rd centile) and left congenital hip dislocation. Maternal grandmother and maternal aunt also showed hypertelorism although they were not formally physically examined.
Discussion
Midline Facial Defects with Ocular Hypertelorism (MFDH) are common features in several conditions. The most frequently clinically recognized anomaly is Frontonasal Dysplasia (FND; OMIM 136760). MFDH is characterized by ocular hypertelorism, bifid nose, cranium bifidum, widow's peak, median cleft lip and (or) lateral cleft lip and cleft palate; structural and functional anomalies of the central nervous system are also often described. They can occur isolated or as part of a syndrome. In most cases the etiology is unknown, possibly because of the relative rarity of MFDH [2] . Cytogenetic imbalances involving different chromosomes [3] and mutations in developmental genes, such as ALX1, ALX3 [4] and ALX4 [5] have been reported in association with craniofrontonasal dysplasias.
We describe occurrence of a mother and a daughter presenting the MFDH phenotype associated with a 2q36.1q36.3 deletion. The phenotype of the mother is significantly milder than that presented by her daughter; this is probably due to the occurrence of the deletion in mosaic form in the mother. Mosaicism comprising a normal cell line and a cell line harboring an unbalanced autosomal structural rearrangement different from a ring or marker chromosome is rare. Nevertheless, cases of mosaicism for pure interstitial deletions or duplications, resulting in parent-to-child transmission, have been previously described. Clinical presentation is known to vary according to somatic mosaicism frequency and tissue distribution [9] . Since only lymphocytes were analyzed here, the tissue distribution and frequency of mosaicism in tissues other than blood remains unknown. The milder phenotype of the mother is probably due to the admixture of deletion and normal cell lines [9] . There are many examples in the literature where mosaicism has arisen at an early embryonic stage in the mother; this either occurs directly in the ovary as a lineage of oogonia, or if prior to gonadal formation, it occurs at an even earlier embryonic stage and both somatic and gonadal lines become established in a mosaic form. It is a reasonable supposition that, as in the mother of the proband described here, the presence of both gonadal and somatic mosaicism indicates the mutation occurred prior to ovary formation. For several disorders including Duchenne and Becker muscular dystrophies, osteogenesis imperfect type II and tuberous sclerosis, in what are apparently new mutation situations a significant increase in recurrence risk occurs due to gonadal mosaicism. The best documented evidence emanates from DMD where, because of both the high mutation rate and disease frequency, it is relative easy to calculate that the average recurrence risk is w7%. This value approximately corresponds also to the frequency of gonadal mosaicism in DMD in ostensibly new mutation situations [10] . The direct relevance of the DMD situation to the interstitial deletion described here is that more than 65% of all DMD mutations are also large interstitial deletions. However, we must assume that unlike DMD, such de novo deletions are normally extremely rare, but when they do so they may also occur as mosaics.
The 6.2 Mb deletion at 2q36 presented by the proband and her mother comprises at least 20 annotated genes. We have listed those genes that appear to be the most relevant to contributing to the phenotype based on their known effect of point mutations or chromosome rearrangements as presented in the OMIM Gene Map and Morbid Map (Table 1) . We also discuss the role of some genes located in the deleted region that were previously related to other clinical phenotypes or mouse mutations.
The phenotype presented by the proband has similarities to the CranioFrontoNasal syndrome (CFNS) normally caused by EFNB1 mutations [6] . Ephrin (EFN) and the Eph receptor (EPH) gene family are widely expressed in the developing brain [7] . The EPHA4 gene is involved in cell proliferation during cerebral cortical development [8] and we believe that the patient's phenotype is partially caused by deletion of this gene.
COL4A3 and COL4A4 mutations, both type IV collagens, cause two syndromes: Alport and Goodpasture. Both of these syndromes are autosomal recessive, and heterozygous deletions are insufficient to cause these diseases. However, we hypothesize that haploinsuffiency of the COL4A3 and COL4A4 genes may explain the skeletal/joint complications observed in the proband.
The deleted region also includes the PAX3 gene, a candidate gene for development of the MFDH phenotype. PAX3 has a crucial role in embryonic development, acting on structures derived from the neural crest and skeletal muscle [11e13] . Alterations in PAX3 are frequently found in the Waardenburg syndrome, which often exhibits ocular hypertelorism and deafness. Although the family reported here was not investigated specifically for deafness, there were no recorded complaints from family member interviews. Abnormalities of the skull, ribs and vertebrae, and fusion of bones in the shoulder and hip regions have also been noted in Pax3
Sp/Sp (Splotch) null mouse embryos [14] .
Another interstitial 2q36 deletion case previously described in the literature by Doco-Fenzy and colleagues [15] present some of the clinical features observed in our patient, including low birth weight, facial dysmorphism, global psychomotor developmental delay and disorders of connective tissue. In the Doco-Fenzy case, the deleted region was smaller (approximately 5.4 Mb) and located more distally on chromosome 2 long arm. Importantly, the EPHA4 and PAX3 genes were not deleted and the patient had no hypertelorism; additionally, she had an enlarged kidney and multiple renal cysts.
The prominant telecanthus and hypertelorism observed in the proband can be best explained by haploinsuffiency of the genes, PAX3 and EPHA4. However, additional patients are needed to define more precisely the phenotypic consequences of deletions in this region.
In the context of this family, molecular cytogenetic testing, including high resolution CGH, FISH and microsatellite analysis, was valuable for genetic counseling purposes, since it demonstrated the mother to be a somatic/gonadal mosaic carrier, where the recurrence risk for a similarly affected child would have been much higher than the practically zero value normally expected with presumptive new mutations.
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